Captor Therapeutics Spolka Akcyjna (CTX.WA)

PLN 47.8

(5.99%)

Net Income Summary of Captor Therapeutics Spolka Akcyjna

  • Captor Therapeutics Spolka Akcyjna's latest annual net income in 2023 was -70.58 Million PLN , down -111.18% from previous year.
  • Captor Therapeutics Spolka Akcyjna's latest quarterly net income in 2024 Q1 was -9.44 Million PLN , up 17.81% from previous quarter.
  • Captor Therapeutics Spolka Akcyjna reported an annual net income of -33.42 Million PLN in 2022, down -1.37% from previous year.
  • Captor Therapeutics Spolka Akcyjna reported an annual net income of -32.97 Million PLN in 2021, down -151.94% from previous year.
  • Captor Therapeutics Spolka Akcyjna reported a quarterly net income of -9.98 Million PLN for 2024 Q2, down -5.76% from previous quarter.
  • Captor Therapeutics Spolka Akcyjna reported a quarterly net income of -11.48 Million PLN for 2023 Q4, up 27.19% from previous quarter.

Annual Net Income Chart of Captor Therapeutics Spolka Akcyjna (2023 - 2017)

Historical Annual Net Income of Captor Therapeutics Spolka Akcyjna (2023 - 2017)

Year Net Income Net Income Growth
2023 -70.58 Million PLN -111.18%
2022 -33.42 Million PLN -1.37%
2021 -32.97 Million PLN -151.94%
2020 -13.08 Million PLN -49.81%
2019 -8.73 Million PLN -97.56%
2018 -4.42 Million PLN -2356.67%
2017 -180 Thousand PLN 0.0%

Peer Net Income Comparison of Captor Therapeutics Spolka Akcyjna

Name Net Income Net Income Difference
Bioceltix S.A. -13.68 Million PLN -415.68%
BIOTON S.A. 2.27 Million PLN 3202.593%
Mabion S.A. 41.26 Million PLN 271.034%
Molecure S.A. -18.3 Million PLN -285.532%
NanoGroup S.A. -7.88 Million PLN -794.621%
Pharmena S.A. 28.94 Million PLN 343.889%
Poltreg S.A. -13.55 Million PLN -420.877%
Pure Biologics Spólka Akcyjna -35.69 Million PLN -97.748%
Ryvu Therapeutics S.A. -92.11 Million PLN 23.372%
Synthaverse S.A. 4.75 Million PLN 1583.48%
Urteste S.A. -5.58 Million PLN -1163.588%